AtriCure rolls out AtriClip FLEX•V Device in U.S

Leading innovator in  treatments for atrial fibrillation (Afib), AtriCure and left atrial appendage management (LAAM) announced the rolling out of AtriClip FLEX•V Left Atrial Appendage (LAA) Exclusion System in the United States. The new AtriClip FLEX•V is the first device of the AtriClip family to offer a clip deployment trigger release. The device also offers an open-ended AtriClip design combined with a tip-first closure mechanism to enable easier navigation and placement in cardiac surgeries.

The AtriClip FLEX•V has a rotatable and malleable shaft allowing cardiac surgeons and hospital staff to adjust the AtriClip to adapt to specific patient anatomies. In addition, the new clip opening handle offers a reduced fatigue design to reposition the AtriClip multiple times before deployment to ensure the device is extended beyond the LAA and at the base.

Mike Carrel, President, and CEO of AtriCure said “This product will enable easier AtriClip deployment in open-chest surgeries, as it combines the lower-profile “V” Clip technology with a redesigned handle enabling a one-handed operation of the device. To date, we have successfully placed over 200 AtriClip PRO•V devices since we launched in September of 2017, and this innovation builds off that momentum. We are excited to see how many more patients we can impact with the addition of the AtriClip FLEX•V to the AtriClip franchise.

 

 

 

Comments (0)
Add Comment